| 1 | A1 | Human | M | 59 y | Stomach (Sto) | Adenocarcinoma | Malignant | T3N0M0 | 2 | II | |
| 1 | A2 | Human | M | 86 y | Stomach (Sto) | Adenocarcinoma | Malignant | T2N0M0 | | IB | |
| 1 | A3 | Human | M | 66 y | Stomach (Sto) | Adenocarcinoma | Malignant | T3N0M0 | 3 | II | |
| 1 | A4 | Human | F | 66 y | Stomach (Sto) | Adenocarcinoma | Malignant | T3N0M0 | 3 | II | |
| 1 | A5 | Human | F | 60 y | Stomach (Sto) | Adenocarcinoma | Malignant | T3N1M0 | 2 | IIIA | |
| 1 | A6 | Human | M | 49 y | Skin, Shoulder (Skn) | Malignant melanoma | Malignant | T3N0M0 | | II | |
| 1 | A7 | Human | M | 36 y | Skin, Back (Skn) | Malignant melanoma | Malignant | T3N0M0 | | II | |
| 1 | A8 | Human | M | 65 y | Skin, Foot sole (Skn) | Malignant melanoma | Malignant | T4N0M0 | | II | |
| 1 | A9 | Human | F | 46 y | Skin, Thigh (Skn) | Malignant melanoma | Malignant | T4N0M0 | | II | |
| 1 | A10 | Human | F | 62 y | Skin, Finger (Skn) | Malignant melanoma | Malignant | T4N0M0 | | II | |
| 1 | A11 | Human | M | 60 y | Prostate (Pst) | Adenocarcinoma | Malignant | T4N1M1c | 2 | IV | |
| 1 | A12 | Human | M | 66 y | Prostate (Pst) | Adenocarcinoma | Malignant | T3N1M1 | 1-2 | IV | |
| 1 | A13 | Human | M | 76 y | Prostate (Pst) | Adenocarcinoma | Malignant | T2aN0M0 | 1-2 | II | |
| 1 | A14 | Human | M | 56 y | Prostate (Pst) | Adenocarcinoma | Malignant | T2N1M1 | 2-3 | IV | |
| 1 | A15 | Human | M | 65 y | Prostate (Pst) | Adenocarcinoma | Malignant | T2N0M0 | 3 | II | |
| 1 | A16 | Human | M | 38 y | Brain (Brn) | Astrocytoma | Tumor | | 2 | | |
| 1 | A17 | Human | F | 36 y | Brain (Brn) | Astrocytoma | Tumor | | 2 | | |
| 1 | A18 | Human | M | 25 y | Brain (Brn) | Astrocytoma | Tumor | | | | |
| 1 | A19 | Human | M | 33 y | Brain (Brn) | Astrocytoma | Tumor | | 2 | | |
| 1 | A20 | Human | M | 36 y | Brain (Brn) | Astrocytoma | Tumor | | 3 | | |
| 1 | A21 | Human | F | 37 y | Ovary (Ova) | Papillary carcinoma, Serous | Malignant | T1N0M0 | 1 | I | |
| 1 | A22 | Human | F | 25 y | Ovary (Ova) | Papillary carcinoma, Serous | Malignant | T1aN0M0 | 1 | IA | |
| 1 | A23 | Human | F | 46 y | Ovary (Ova) | Mucinous papillary carcinoma | Malignant | T1N0M0 | 1 | I | |
| 1 | A24 | Human | F | 32 y | Ovary (Ova) | Mucinous papillary carcinoma with necrosis | Malignant | T1N0M0 | | I | |
| 1 | A25 | Human | F | 42 y | Ovary (Ova) | Cystadenocarcinoma, Serous | Malignant | T1bN0M0 | 3 | IB | |
| 1 | B1 | Human | M | 63 y | Stomach, Smooth muscle (Sto) | Adenocarcinoma | Malignant | T3N1M0 | | IIIA | |
| 1 | B2 | Human | M | 62 y | Stomach (Sto) | Adenocarcinoma | Malignant | T3N1M0 | 2 | IIIA | |
| 1 | B3 | Human | F | 49 y | Stomach (Sto) | Adenocarcinoma | Malignant | T3N1M0 | 2 | IIIA | |
| 1 | B4 | Human | M | 53 y | Stomach (Sto) | Adenocarcinoma | Malignant | T2N0M0 | 2 | IB | |
| 1 | B5 | Human | M | 49 y | Stomach (Sto) | Adenocarcinoma | Malignant | T3N0M0 | 2 | II | |
| 1 | B6 | Human | M | 70 y | Skin, Foot sole (Skn) | Malignant melanoma | Malignant | T4N0M0 | | II | |
| 1 | B7 | Human | F | 66 y | Skin, Chest wall (Skn) | Malignant melanoma | Malignant | T4N0M0 | | II | |
| 1 | B8 | Human | M | 25 y | Skin, Heel (Skn) | Malignant melanoma | Malignant | T4N0M0 | | II | |
| 1 | B9 | Human | F | 38 y | Skin, Toe (Skn) | Malignant melanoma | Malignant | T4N0M0 | | II | |
| 1 | B10 | Human | M | 52 y | Skin, Heel (Skn) | Malignant melanoma | Malignant | T4N1M1 | | IV | |
| 1 | B11 | Human | M | 64 y | Prostate (Pst) | Adenocarcinoma | Malignant | T3N0M1 | 2 | IV | |
| 1 | B12 | Human | M | 74 y | Prostate (Pst) | Adenocarcinoma | Malignant | T4N1M1c | 3 | IV | |
| 1 | B13 | Human | M | 82 y | Prostate (Pst) | Adenocarcinoma | Malignant | T3N2M1c | 2 | IV | |
| 1 | B14 | Human | M | 75 y | Prostate (Pst) | Adenocarcinoma | Malignant | T2N1M1c | 3 | IV | |
| 1 | B15 | Human | M | 69 y | Prostate (Pst) | Adenocarcinoma | Malignant | T3N0M0 | 2 | III | |
| 1 | B16 | Human | F | 50 y | Brain, Cerebrum (Brn) | Glioblastoma | Malignant | | 3-4 | | |
| 1 | B17 | Human | F | 51 y | Brain, Cerebrum (Brn) | Astrocytoma | Tumor | | 2-3 | | |
| 1 | B18 | Human | M | 41 y | Brain, Cerebrum (Brn) | Astrocytoma | Tumor | | 2 | | |
| 1 | B19 | Human | F | 55 y | Brain, Cerebrum (Brn) | Astrocytoma | Tumor | | 2-3 | | |
| 1 | B20 | Human | M | 51 y | Brain, Cerebrum (Brn) | Glioblastoma | Malignant | | 3-4 | | |
| 1 | B21 | Human | F | 48 y | Ovary (Ova) | Mucinous papillary carcinoma | Malignant | T1N0M0 | 1-2 | I | |
| 1 | B22 | Human | F | 26 y | Ovary (Ova) | Mucinous papillary carcinoma | Malignant | T1N0M0 | 2 | I | |
| 1 | B23 | Human | F | 56 y | Ovary (Ova) | Endometrioid carcinoma | Malignant | T1N0M0 | | I | |
| 1 | B24 | Human | F | 52 y | Ovary (Ova) | Papillary carcinoma, Serous | Malignant | T1aN0M0 | 3 | IA | |
| 1 | B25 | Human | F | 69 y | Ovary (Ova) | Papillary carcinoma, Serous | Malignant | T2N0M0 | 3 | II | |
| 1 | C1 | Human | M | 62 y | Stomach (Sto) | Adenocarcinoma | Malignant | T3N0M0 | 2 | II | |
| 1 | C2 | Human | F | 72 y | Stomach (Sto) | Adenocarcinoma | Malignant | T3N0M0 | 3 | II | |
| 1 | C3 | Human | M | 75 y | Stomach (Sto) | Adenocarcinoma | Malignant | T3N0M0 | 2 | II | |
| 1 | C4 | Human | M | 52 y | Stomach (Sto) | Adenocarcinoma | Malignant | T1N0M0 | 2 | IA | |
| 1 | C5 | Human | M | 37 y | Stomach, Gastric mucosa (Sto) | Adenocarcinoma | Malignant | T1N0M0 | | IA | |
| 1 | C6 | Human | F | 88 y | Skin, Foot sole (Skn) | Malignant melanoma | Malignant | T4N0M1 | | IV | |
| 1 | C7 | Human | M | 57 y | Skin, Shoulder (Skn) | Malignant melanoma | Malignant | T4N0M0 | | II | |
| 1 | C8 | Human | F | 54 y | Skin, Foot sole (Skn) | Malignant melanoma | Malignant | T4N0M0 | | II | |
| 1 | C9 | Human | M | 65 y | Skin, Finger (Skn) | Malignant melanoma | Malignant | T4N0M0 | | II | |
| 1 | C10 | Human | F | 42 y | Skin, Finger (Skn) | Malignant melanoma | Malignant | T4N0M0 | | II | |
| 1 | C11 | Human | M | 64 y | Prostate (Pst) | Adenocarcinoma | Malignant | T2aN0M0 | 2 | II | |
| 1 | C12 | Human | M | 72 y | Prostate (Pst) | Adenocarcinoma | Malignant | T2N0M0 | 2 | II | |
| 1 | C13 | Human | M | 62 y | Prostate (Pst) | Adenocarcinoma | Malignant | T3N1M1b | 2 | IV | |
| 1 | C14 | Human | M | 80 y | Prostate (Pst) | Adenocarcinoma | Malignant | T4N1M1c | 2 | IV | |
| 1 | C15 | Human | M | 51 y | Prostate (Pst) | Adenocarcinoma | Malignant | T2N0M0 | 2-3 | II | |
| 1 | C16 | Human | M | 53 y | Brain, Cerebrum (Brn) | Astrocytoma | Tumor | | 2-3 | | |
| 1 | C17 | Human | F | 52 y | Brain, Cerebrum (Brn) | Glioblastoma | Malignant | | 4 | | |
| 1 | C18 | Human | M | 41 y | Brain, Cerebrum (Brn) | Astrocytoma | Tumor | | 2-3 | | |
| 1 | C19 | Human | M | 62 y | Brain, Cerebrum (Brn) | Astrocytoma | Tumor | | 2-3 | | |
| 1 | C20 | Human | M | 60 y | Brain, Cerebrum, Glia (Brn) | Astrocytoma with hyperplasia | Tumor | | | | |
| 1 | C21 | Human | F | 59 y | Ovary (Ova) | Papillary carcinoma, Serous | Malignant | T2N0M0 | 3 | II | |
| 1 | C22 | Human | F | 26 y | Ovary (Ova) | Papillary carcinoma, Serous | Malignant | T1N0M0 | 2 | I | |
| 1 | C23 | Human | F | 56 y | Ovary (Ova) | Papillary carcinoma, Serous | Malignant | T2N1M0 | 3 | IIIC | |
| 1 | C24 | Human | F | 49 y | Ovary (Ova) | Papillary carcinoma, Serous | Malignant | T1N0M0 | 3 | I | |
| 1 | C25 | Human | F | 48 y | Ovary (Ova) | Papillary carcinoma, Serous | Malignant | T2bN0M0 | 3 | IIB | |
| 1 | D1 | Human | M | 68 y | Stomach (Sto) | Adenocarcinoma | Malignant | T3N0M0 | | II | |
| 1 | D2 | Human | M | 56 y | Stomach, Gastric mucosa (Sto) | Adenocarcinoma | Malignant | T3N1M0 | | IIIA | |
| 1 | D3 | Human | M | 58 y | Stomach (Sto) | Adenocarcinoma | Malignant | T3N0M0 | 1 | II | |
| 1 | D4 | Human | M | 53 y | Stomach (Sto) | Adenocarcinoma | Malignant | T3N1M0 | 2 | IIIA | |
| 1 | D5 | Human | M | 64 y | Stomach (Sto) | Adenocarcinoma | Malignant | T3N1M0 | 3 | IIIA | |
| 1 | D6 | Human | F | 58 y | Skin, Buttock (Skn) | Malignant melanoma | Malignant | T4N0M0 | | II | |
| 1 | D7 | Human | M | 38 y | Skin, Abdominal wall (Skn) | Malignant melanoma | Malignant | T4N1M0 | | III | |
| 1 | D8 | Human | M | 76 y | Skin, Foot (Skn) | Malignant melanoma | Malignant | T4N0M0 | | II | |
| 1 | D9 | Human | F | 54 y | Skin, Foot sole (Skn) | Malignant melanoma | Malignant | T4N0M0 | | II | |
| 1 | D10 | Human | M | 55 y | Skin, Forearm (Skn) | Malignant melanoma | Malignant | T4N0M0 | | II | |
| 1 | D11 | Human | M | 67 y | Prostate (Pst) | Adenocarcinoma | Malignant | T2N0M1 | 2 | IV | |
| 1 | D12 | Human | M | 62 y | Prostate (Pst) | Adenocarcinoma | Malignant | T2N0M0 | 3 | II | |
| 1 | D13 | Human | M | 65 y | Prostate, Fibrous tissue and blood vessel (Pst) | Adenocarcinoma | Malignant | T2N0M0 | | II | |
| 1 | D14 | Human | M | 72 y | Prostate (Pst) | Adenocarcinoma | Malignant | T2N0M0 | 2 | II | |
| 1 | D15 | Human | M | 81 y | Prostate (Pst) | Adenocarcinoma | Malignant | T3N0M0 | 2-3 | III | |
| 1 | D16 | Human | M | 12 y | Brain, Cerebrum, Glia (Brn) | Astrocytoma with hyperplasia | Tumor | | | | |
| 1 | D17 | Human | M | 59 y | Brain, Cerebrum (Brn) | Glioblastoma | Malignant | | 4 | | |
| 1 | D18 | Human | M | 43 y | Brain, Cerebrum (Brn) | Glioblastoma | Malignant | | 4 | | |
| 1 | D19 | Human | F | 6 y | Brain, Cerebrum (Brn) | Glioblastoma | Malignant | | 4 | | |
| 1 | D20 | Human | M | 17 y | Brain, Cerebrum (Brn) | Oligodendroglioma, Malignant | Malignant | | | | |
| 1 | D21 | Human | F | 39 y | Ovary (Ova) | Papillary carcinoma, Serous | Malignant | T2N0M0 | 3 | II | |
| 1 | D22 | Human | F | 52 y | Ovary (Ova) | Papillary carcinoma, Serous | Malignant | T2N0M0 | 2 | II | |
| 1 | D23 | Human | F | 40 y | Ovary (Ova) | Papillary carcinoma, Serous | Malignant | T1N0M0 | 3 | I | |
| 1 | D24 | Human | F | 56 y | Ovary (Ova) | Papillary carcinoma, Serous | Malignant | T2N0M0 | 3 | II | |
| 1 | D25 | Human | F | 48 y | Ovary (Ova) | Papillary carcinoma, Serous | Malignant | T3cN1M1 | 3 | IV | |
| 1 | E1 | Human | M | 56 y | Stomach, Smooth muscle (Sto) | Normal | Benign non-neoplastic | | | | |
| 1 | E2 | Human | F | 50 y | Stomach (Sto) | Normal | Benign non-neoplastic | | | | |
| 1 | E3 | Human | M | 49 y | Stomach (Sto) | Normal | Benign non-neoplastic | | | | |
| 1 | E4 | Human | F | 15 y | Stomach, Gastric mucosa (Sto) | Inflammation, Chronic | Inflammatory | | | | |
| 1 | E5 | Human | M | 48 y | Stomach (Sto) | Normal | Benign non-neoplastic | | | | |
| 1 | E6 | Human | F | 28 y | Breast (Bst) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | E7 | Human | F | 30 y | Breast (Bst) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | E8 | Human | F | 30 y | Breast (Bst) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | E9 | Human | F | 35 y | Breast (Bst) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | E10 | Human | F | 39 y | Breast (Bst) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | E11 | Human | M | 27 y | Prostate (Pst) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | E12 | Human | M | 68 y | Prostate (Pst) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | E13 | Human | M | 63 y | Prostate (Pst) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | E14 | Human | M | 52 y | Prostate (Pst) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | E15 | Human | M | 43 y | Prostate (Pst) | Normal | Benign non-neoplastic | | | | |
| 1 | E16 | Human | F | 44 y | Brain (Brn) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | E17 | Human | M | 41 y | Brain (Brn) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | E18 | Human | F | 33 y | Brain (Brn) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | E19 | Human | F | 37 y | Brain (Brn) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | E20 | Human | M | 39 y | Brain (Brn) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | E21 | Human | F | 39 y | Ovary (Ova) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | E22 | Human | F | 39 y | Ovary (Ova) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | E23 | Human | F | 31 y | Ovary (Ova) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | E24 | Human | F | 53 y | Ovary (Ova) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | E25 | Human | F | 45 y | Ovary (Ova) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | F1 | Human | F | 42 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T2N0M0 | 2 | IIA | |
| 1 | F2 | Human | F | 50 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T2N0M0 | 2 | IIA | |
| 1 | F3 | Human | F | 47 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T2N0M0 | 2 | IIA | |
| 1 | F4 | Human | F | 47 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T1N0M0 | 2 | I | |
| 1 | F5 | Human | F | 53 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T2N0M0 | 2 | IIA | |
| 1 | F6 | Human | M | 50 y | Testis (Tes) | Seminoma | Tumor | T1N0M0 | | I | |
| 1 | F7 | Human | M | 43 y | Testis (Tes) | Seminoma | Tumor | T1N0M0 | | I | |
| 1 | F8 | Human | M | 42 y | Testis (Tes) | Seminoma | Tumor | T1N0M0 | | I | |
| 1 | F9 | Human | M | 40 y | Testis (Tes) | Seminoma | Tumor | T2N0M0 | | I | |
| 1 | F10 | Human | M | 32 y | Testis (Tes) | Seminoma | Tumor | T2N0M0 | | I | |
| 1 | F11 | Human | M | 73 y | Colon (Col) | Adenocarcinoma | Malignant | T4N0M0 | 2 | II | |
| 1 | F12 | Human | M | 53 y | Colon (Col) | Adenocarcinoma | Malignant | T4N0M0 | 2 | II | |
| 1 | F13 | Human | F | 74 y | Colon, Fibrous tissue (Col) | Adenocarcinoma | Malignant | T4N0M0 | | II | |
| 1 | F14 | Human | M | 55 y | Colon (Col) | Adenocarcinoma | Malignant | T4N0M0 | 2 | II | |
| 1 | F15 | Human | F | 79 y | Colon (Col) | Adenocarcinoma | Malignant | T4N0M0 | 2 | II | |
| 1 | F16 | Human | M | 61 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2N0M0 | 1-2 | II | |
| 1 | F17 | Human | M | 76 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T1N0M0 | 1-2 | I | |
| 1 | F18 | Human | M | 80 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T3N0M0 | 2 | II | |
| 1 | F19 | Human | M | 63 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2N0M0 | 2 | II | |
| 1 | F20 | Human | F | 56 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2N0M0 | 2 | II | |
| 1 | F21 | Human | F | 51 y | Uterus, Endometrium (Ute) | Adenocarcinoma | Malignant | T1aN0M0 | 1 | IA | |
| 1 | F22 | Human | F | 40 y | Uterus, Endometrium (Ute) | Adenocarcinoma | Malignant | T2aN0M0 | 2 | IIA | |
| 1 | F23 | Human | F | 61 y | Uterus, Endometrium (Ute) | Adenocarcinoma | Malignant | T1cN0M0 | 2 | IC | |
| 1 | F24 | Human | F | 40 y | Uterus, Endometrium (Ute) | Adenocarcinoma | Malignant | T1bN0M0 | 1 | IB | |
| 1 | F25 | Human | F | 51 y | Uterus, Endometrium (Ute) | Adenocarcinoma | Malignant | T1bN0M0 | 2 | IB | |
| 1 | G1 | Human | F | 44 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T2N0M0 | 2 | IIA | |
| 1 | G2 | Human | F | 48 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T2N0M0 | 2 | IIA | |
| 1 | G3 | Human | F | 56 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T1N0M0 | 2 | I | |
| 1 | G4 | Human | F | 77 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T2N0M0 | 2 | IIA | |
| 1 | G5 | Human | F | 41 y | Breast, Fibrous tissue (Bst) | Ductal carcinoma, infiltrating | Malignant | T2N0M0 | | IIA | |
| 1 | G6 | Human | M | 38 y | Testis (Tes) | Seminoma | Tumor | T2N0M0 | | I | |
| 1 | G7 | Human | M | 28 y | Testis (Tes) | Seminoma | Tumor | T2N0M0 | | I | |
| 1 | G8 | Human | M | 56 y | Testis (Tes) | Seminoma | Tumor | T2N0M0 | | I | |
| 1 | G9 | Human | M | 34 y | Testis (Tes) | Seminoma | Tumor | T1N0M0 | | I | |
| 1 | G10 | Human | M | 27 y | Testis (Tes) | Seminoma | Tumor | T1N0M0 | | I | |
| 1 | G11 | Human | F | 54 y | Colon (Col) | Adenocarcinoma | Malignant | T4N0M0 | 2 | II | |
| 1 | G12 | Human | F | 58 y | Colon (Col) | Adenocarcinoma | Malignant | T4N0M0 | 2 | II | |
| 1 | G13 | Human | M | 66 y | Colon, Mucosa (Col) | Adenocarcinoma with necrosis | Malignant | T4N0M0 | | II | |
| 1 | G14 | Human | F | 63 y | Colon (Col) | Adenocarcinoma | Malignant | T2N0M0 | 2 | I | |
| 1 | G15 | Human | M | 46 y | Colon (Col) | Adenocarcinoma | Malignant | T4N0M0 | 2 | II | |
| 1 | G16 | Human | M | 45 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2N0M0 | 2 | II | |
| 1 | G17 | Human | F | 37 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T1N0M0 | 2 | I | |
| 1 | G18 | Human | F | 79 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2N0M0 | 2 | II | |
| 1 | G19 | Human | M | 78 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2N0M0 | | II | |
| 1 | G20 | Human | M | 71 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2N0M0 | 2 | II | |
| 1 | G21 | Human | F | 68 y | Uterus, Endometrium (Ute) | Adenocarcinoma | Malignant | T1cN0M0 | 2 | IC | |
| 1 | G22 | Human | F | 62 y | Uterus, Endometrium (Ute) | Adenocarcinoma | Malignant | T1cN0M0 | 1 | IC | |
| 1 | G23 | Human | F | 40 y | Uterus, Endometrium (Ute) | Adenocarcinoma | Malignant | T2N0M0 | 1 | II | |
| 1 | G24 | Human | F | 55 y | Uterus, Endometrium (Ute) | Adenocarcinoma | Malignant | T1cN0M0 | 2 | IC | |
| 1 | G25 | Human | F | 50 y | Uterus, Endometrium (Ute) | Adenocarcinoma | Malignant | T1bN0M0 | 2 | IB | |
| 1 | H1 | Human | F | 46 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T2N0M0 | 2 | IIA | |
| 1 | H2 | Human | F | 50 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T1N0M0 | 3 | I | |
| 1 | H3 | Human | F | 50 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T2N0M0 | 2 | IIA | |
| 1 | H4 | Human | F | 55 y | Breast, Fibrofatty tissue (Bst) | Ductal carcinoma, infiltrating | Malignant | T1N0M0 | | I | |
| 1 | H5 | Human | F | 51 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T4N0M0 | 2 | IIIB | |
| 1 | H6 | Human | M | 52 y | Testis (Tes) | Seminoma | Tumor | T2N0M0 | | I | |
| 1 | H7 | Human | M | 47 y | Testis (Tes) | Seminoma | Tumor | T1N0M0 | | I | |
| 1 | H8 | Human | M | 41 y | Testis (Tes) | Seminoma | Tumor | T1N0M0 | | I | |
| 1 | H9 | Human | M | 15 y | Testis (Tes) | Seminoma | Tumor | T1N0M0 | | I | |
| 1 | H10 | Human | M | 51 y | Testis, Fibrous tissue and blood vessel (Tes) | Seminoma | Tumor | T1N0M0 | | I | |
| 1 | H11 | Human | F | 78 y | Colon (Col) | Adenocarcinoma | Malignant | T4N0M0 | 2 | II | |
| 1 | H12 | Human | M | 57 y | Colon (Col) | Adenocarcinoma | Malignant | T4N0M0 | 2 | II | |
| 1 | H13 | Human | F | 57 y | Colon (Col) | Adenocarcinoma | Malignant | T2N0M0 | 2 | I | |
| 1 | H14 | Human | M | 46 y | Colon (Col) | Adenocarcinoma | Malignant | T4N0M0 | 3 | II | |
| 1 | H15 | Human | M | 37 y | Colon (Col) | Adenocarcinoma | Malignant | T4N0M0 | 3 | II | |
| 1 | H16 | Human | M | 54 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2N0M0 | 3 | II | |
| 1 | H17 | Human | F | 73 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2N0M0 | 3 | II | |
| 1 | H18 | Human | M | 76 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2N0M0 | 3 | II | |
| 1 | H19 | Human | M | 56 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T1N0M0 | 3 | I | |
| 1 | H20 | Human | M | 70 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T1N0M0 | 3 | I | |
| 1 | H21 | Human | F | 65 y | Uterus, Endometrium (Ute) | Adenocarcinoma | Malignant | T1cN0M0 | 2 | IC | |
| 1 | H22 | Human | F | 48 y | Uterus, Endometrium (Ute) | Adenocarcinoma | Malignant | T2N0M0 | 2 | II | |
| 1 | H23 | Human | F | 56 y | Uterus, Endometrium (Ute) | Adenocarcinoma with necrosis | Malignant | T1N0M0 | | I | |
| 1 | H24 | Human | F | 59 y | Uterus, Endometrium (Ute) | Adenocarcinoma | Malignant | T1cN0M0 | 2 | IC | |
| 1 | H25 | Human | F | 46 y | Uterus, Endometrium (Ute) | Adenocarcinoma | Malignant | T2bN0M0 | 3 | IIB | |
| 1 | I1 | Human | F | 40 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T2N0M0 | 2-3 | IIA | |
| 1 | I2 | Human | F | 62 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T1N0M0 | | I | |
| 1 | I3 | Human | F | 50 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T4N1M0 | 2 | IIIB | |
| 1 | I4 | Human | F | 48 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T1N0M0 | 3 | I | |
| 1 | I5 | Human | F | 50 y | Breast (Bst) | Ductal carcinoma, infiltrating | Malignant | T4N1M0 | 3 | IIIB | |
| 1 | I6 | Human | M | 25 y | Testis (Tes) | Embryonal carcinoma | Malignant | T4N1M0 | | II | |
| 1 | I7 | Human | M | 38 y | Testis (Tes) | Embryonal carcinoma | Malignant | T1N0M0 | | I | |
| 1 | I8 | Human | M | 43 y | Testis (Tes) | Embryonal carcinoma | Malignant | T2N0M0 | | I | |
| 1 | I9 | Human | M | 36 y | Testis (Tes) | Embryonal carcinoma | Malignant | T1N0M0 | | I | |
| 1 | I10 | Human | M | 30 y | Testis (Tes) | Embryonal carcinoma | Malignant | T2N0M0 | | I | |
| 1 | I11 | Human | M | 70 y | Colon (Col) | Adenocarcinoma, Mucinous | Malignant | T4N0M0 | 3 | II | |
| 1 | I12 | Human | F | 48 y | Colon (Col) | Adenocarcinoma | Malignant | T4N2M1 | 3 | IV | |
| 1 | I13 | Human | M | 72 y | Colon (Col) | Adenocarcinoma | Malignant | T4N0M0 | | II | |
| 1 | I14 | Human | F | 34 y | Colon (Col) | Adenocarcinoma | Malignant | T4N0M0 | 3 | II | |
| 1 | I15 | Human | M | 71 y | Colon (Col) | Adenocarcinoma with signet-ring cell carcinoma | Malignant | T4N0M0 | 3 | II | |
| 1 | I16 | Human | M | 78 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2N0M0 | 3 | II | |
| 1 | I17 | Human | F | 48 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2N0M0 | 3 | II | |
| 1 | I18 | Human | F | 37 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T2N0M0 | 3 | II | |
| 1 | I19 | Human | M | 58 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T1N0M0 | 3 | I | |
| 1 | I20 | Human | M | 52 y | Bladder (Bla) | Transitional cell carcinoma | Malignant | T3N0M0 | 3 | II | |
| 1 | I21 | Human | F | 60 y | Uterus, Endometrium (Ute) | Adenocarcinoma | Malignant | T1cN0M0 | 3 | IC | |
| 1 | I22 | Human | F | 56 y | Uterus, Endometrium, Smooth muscle (Ute) | Adenocarcinoma | Malignant | T2aN0M0 | | IIA | |
| 1 | I23 | Human | F | 51 y | Uterus, Endometrium (Ute) | Adenocarcinoma | Malignant | T1aN0M0 | 2 | IA | |
| 1 | I24 | Human | F | 55 y | Uterus, Endometrium (Ute) | Adenocarcinoma | Malignant | T1bN0M0 | 3 | IB | |
| 1 | I25 | Human | F | 53 y | Uterus, Endometrium (Ute) | Adenocarcinoma | Malignant | T1cN0M0 | 3 | IC | |
| 1 | J1 | Human | F | 43 y | Breast, Fibrofatty tissue (Bst) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | J2 | Human | F | 50 y | Breast (Bst) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | J3 | Human | F | 53 y | Breast (Bst) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | J4 | Human | F | 40 y | Breast (Bst) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | J5 | Human | F | 51 y | Breast, Fibrous tissue (Bst) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | J6 | Human | M | 65 y | Testis (Tes) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | J7 | Human | M | 74 y | Testis (Tes) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | J8 | Human | M | 74 y | Testis (Tes) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | J9 | Human | M | 61 y | Testis (Tes) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | J10 | Human | M | 69 y | Testis (Tes) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | J11 | Human | F | 70 y | Colon (Col) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | J12 | Human | M | 57 y | Colon, Fibrous tissue, smooth muscle and blood vessel (Col) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | J13 | Human | M | 35 y | Colon (Col) | Normal | Benign non-neoplastic | | | | |
| 1 | J14 | Human | M | 69 y | Colon (Col) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | J15 | Human | F | 21 y | Colon (Col) | Normal | Benign non-neoplastic | | | | |
| 1 | J16 | Human | M | 6 mo | Bladder (Bla) | Normal | Benign non-neoplastic | | | | |
| 1 | J17 | Human | M | 50 y | Bladder (Bla) | Normal | Benign non-neoplastic | | | | |
| 1 | J18 | Human | M | 35 y | Bladder (Bla) | Normal | Benign non-neoplastic | | | | |
| 1 | J19 | Human | M | 22 y | Bladder (Bla) | Normal | Benign non-neoplastic | | | | |
| 1 | J20 | Human | M | 48 y | Bladder, Smooth muscle (Bla) | Normal | Benign non-neoplastic | | | | |
| 1 | J21 | Human | F | 40 y | Cervix, Endometrium (Cvx) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | J22 | Human | F | 37 y | Cervix, Endometrium (Cvx) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | J23 | Human | F | 39 y | Cervix, Endometrium (Cvx) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | J24 | Human | F | 45 y | Cervix, Endometrium (Cvx) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | J25 | Human | F | 30 y | Ovary, Endometrium (Ova) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | K1 | Human | F | 36 y | Thyroid (Tyd) | Papillary carcinoma | Malignant | T3N0M0 | 1 | I | |
| 1 | K2 | Human | F | 36 y | Thyroid (Tyd) | Papillary carcinoma | Malignant | T2N0M0 | 2 | I | |
| 1 | K3 | Human | F | 65 y | Thyroid (Tyd) | Papillary carcinoma | Malignant | T2N0M0 | 1 | II | |
| 1 | K4 | Human | M | 49 y | Thyroid (Tyd) | Papillary carcinoma | Malignant | T4N1M0 | 1 | III | |
| 1 | K5 | Human | F | 70 y | Thyroid (Tyd) | Papillary carcinoma | Malignant | T2N0M0 | 1 | II | |
| 1 | K6 | Human | M | 65 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T3N0M0 | 1 | II | |
| 1 | K7 | Human | M | 56 y | Lung, Fibrous tissue (Lng) | Squamous cell carcinoma with chronic inflammation | Malignant | T1N0M0 | | I | |
| 1 | K8 | Human | M | 60 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N0M0 | 2 | I | |
| 1 | K9 | Human | M | 54 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N3M0 | 2 | IIIB | |
| 1 | K10 | Human | M | 61 y | Lung (Lng) | Squamous cell carcinoma with necrosis | Malignant | T2N0M0 | | I | |
| 1 | K11 | Human | F | 51 y | Cheek (Chk) | Squamous cell carcinoma | Malignant | T4N0M0 | | IV | |
| 1 | K12 | Human | M | 40 y | Jaw (Jaw) | Squamous cell carcinoma | Malignant | T4N0M0 | 1 | IV | |
| 1 | K13 | Human | M | 70 y | Cheek (Chk) | Squamous cell carcinoma | Malignant | T2N0M0 | | II | |
| 1 | K14 | Human | M | 45 y | Scalp (Sca) | Squamous cell carcinoma | Malignant | T1N0M0 | 3 | I | |
| 1 | K15 | Human | F | 70 y | Lip (Lip) | Squamous cell carcinoma | Malignant | T1N0M0 | 2 | I | |
| 1 | K16 | Human | M | 17 y | Lymph node, Neck (Lym) | Hodgkin's lymphoma, Mixed | Malignant | | | | |
| 1 | K17 | Human | F | 22 y | Lymph node, Lung (Lym) | Hodgkin's lymphoma, Mixed | Malignant | | | | |
| 1 | K18 | Human | F | 31 y | Lymph node, Clavicle (Lym) | Hodgkin's lymphoma, Mixed | Malignant | | | | |
| 1 | K19 | Human | M | 50 y | Lymph node, Axilla (Lym) | Hodgkin's lymphoma, Mixed | Malignant | | | | |
| 1 | K20 | Human | M | 68 y | Lymph node, Parotid gland (Lym) | Hodgkin's lymphoma with nodular sclerosis | Malignant | | | | |
| 1 | K21 | Human | F | 60 y | Soft tissue, Abdominal wall (Sft) | Fibrosarcoma | Malignant | T2bN0M0 | Low | IB | |
| 1 | K22 | Human | F | 39 y | Soft tissue, Leg (Sft) | Fibrosarcoma | Malignant | T1N0M0 | Low | IA | |
| 1 | K23 | Human | F | 38 y | Soft tissue, Chest wall (Sft) | Fibrosarcoma | Malignant | T1bN0M0 | Low | IA | |
| 1 | K24 | Human | M | 32 y | Soft tissue, Scalp (Sft) | Fibrosarcoma | Malignant | T1bN0M0 | Low | IA | |
| 1 | K25 | Human | M | 52 y | Soft tissue, Thigh (Sft) | Fibrosarcoma | Malignant | T1bN0M0 | High | IIIA | |
| 1 | L1 | Human | F | 39 y | Thyroid (Tyd) | Papillary carcinoma | Malignant | T2N0M0 | 1 | I | |
| 1 | L2 | Human | F | 46 y | Thyroid (Tyd) | Papillary carcinoma | Malignant | T2N0M0 | 1-2 | II | |
| 1 | L3 | Human | F | 28 y | Thyroid (Tyd) | Papillary carcinoma | Malignant | T2N0M0 | 1-2 | I | |
| 1 | L4 | Human | F | 29 y | Thyroid (Tyd) | Papillary carcinoma | Malignant | T1N0M0 | 1 | I | |
| 1 | L5 | Human | F | 61 y | Thyroid (Tyd) | Papillary carcinoma | Malignant | T3N0M0 | 2 | II | |
| 1 | L6 | Human | M | 53 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T1N0M0 | | I | |
| 1 | L7 | Human | M | 48 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N0M0 | 2 | I | |
| 1 | L8 | Human | M | 69 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T1N0M0 | 2 | I | |
| 1 | L9 | Human | M | 65 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N1M0 | 2 | II | |
| 1 | L10 | Human | M | 76 y | Lung (Lng) | Squamous cell carcinoma | Malignant | T2N1M0 | 2 | II | |
| 1 | L11 | Human | M | 74 y | Neck (Nec) | Squamous cell carcinoma | Malignant | T2N0M0 | 2 | II | |
| 1 | L12 | Human | M | 34 y | Head (Hed) | Squamous cell carcinoma | Malignant | T3N0M0 | 1 | II | |
| 1 | L13 | Human | M | 49 y | Gingiva (Gin) | Squamous cell carcinoma | Malignant | T4N0M0 | 2 | IV | |
| 1 | L14 | Human | F | 60 y | Head (Hed) | Squamous cell carcinoma | Malignant | T1N0M0 | 1 | I | |
| 1 | L15 | Human | M | 75 y | Sinus, Maxillary (Sin) | Squamous cell carcinoma | Malignant | T4N0M0 | 2 | IV | |
| 1 | L16 | Human | F | 48 y | Lymph node, Groin (Lym) | Hodgkin's lymphoma, Mixed | Malignant | | | | |
| 1 | L17 | Human | M | 41 y | Lymph node, Cheek (Lym) | Hodgkin's lymphoma, Mixed | Malignant | | | | |
| 1 | L18 | Human | M | 32 y | Lymph node, Neck (Lym) | Hodgkin's lymphoma, Mixed | Malignant | | | | |
| 1 | L19 | Human | M | 27 y | Lymph node, Groin (Lym) | Hodgkin's lymphoma, Mixed | Malignant | | | | |
| 1 | L20 | Human | F | 42 y | Lymph node, Neck (Lym) | Hodgkin's lymphoma with lymphocytic predominance | Malignant | | | | |
| 1 | L21 | Human | F | 35 y | Soft tissue, Thigh (Sft) | Fibrosarcoma | Malignant | T1bN0M0 | Intermediate | IIIA | |
| 1 | L22 | Human | M | 40 y | Soft tissue, Arm (Sft) | Fibrosarcoma | Malignant | T2bN0M0 | Intermediate | IIIB | |
| 1 | L23 | Human | F | 27 y | Soft tissue, Abdominal wall (Sft) | Fibrosarcoma | Malignant | T2aN0M0 | Intermediate | IIB | |
| 1 | L24 | Human | M | 34 y | Soft tissue, Thigh (Sft) | Fibrosarcoma | Malignant | T2aN0M0 | High | IIIB | |
| 1 | L25 | Human | M | 27 y | Soft tissue, Back (Sft) | Fibrosarcoma | Malignant | T1aN0M0 | Intermediate | IIA | |
| 1 | M1 | Human | F | 63 y | Thyroid (Tyd) | Follicular carcinoma | Malignant | T4N0M0 | 1 | III | |
| 1 | M2 | Human | F | 57 y | Thyroid (Tyd) | Follicular carcinoma | Malignant | T4N0M0 | 2 | III | |
| 1 | M3 | Human | F | 36 y | Thyroid (Tyd) | Follicular carcinoma | Malignant | T3N0M0 | 2 | I | |
| 1 | M4 | Human | M | 62 y | Thyroid (Tyd) | Follicular carcinoma | Malignant | T2N0M0 | 1 | II | |
| 1 | M5 | Human | F | 50 y | Thyroid (Tyd) | Follicular carcinoma | Malignant | T3N0M0 | 2 | II | |
| 1 | M6 | Human | M | 47 y | Lung (Lng) | Adenocarcinoma, Papillary | Malignant | T1N0M0 | 1 | I | |
| 1 | M7 | Human | M | 70 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N0M0 | 2 | I | |
| 1 | M8 | Human | M | 70 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N0M0 | 2 | I | |
| 1 | M9 | Human | M | 58 y | Lung (Lng) | Adenocarcinoma, Papillary | Malignant | T2N1M0 | 2 | II | |
| 1 | M10 | Human | M | 62 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N0M0 | 2 | I | |
| 1 | M11 | Human | M | 65 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T2N0M0 | 2 | II | |
| 1 | M12 | Human | M | 42 y | Nasal cavity (Nsl) | Squamous cell carcinoma | Malignant | T1N0M0 | 2 | I | |
| 1 | M13 | Human | F | 45 y | Nasal cavity (Nsl) | Squamous cell carcinoma | Malignant | T1N0M0 | 2 | I | |
| 1 | M14 | Human | M | 58 y | Scalp (Sca) | Squamous cell carcinoma | Malignant | T1N0M0 | 1 | I | |
| 1 | M15 | Human | M | 43 y | Nasal cavity (Nsl) | Squamous cell carcinoma | Malignant | T3N0M0 | 3 | II | |
| 1 | M16 | Human | F | 43 y | Lymph node, Stomach (Lym) | Diffuse B-cell lymphoma | Malignant | | | | |
| 1 | M17 | Human | M | 43 y | Lymph node, Small intestine (Lym) | Diffuse B-cell lymphoma | Malignant | | | | |
| 1 | M18 | Human | F | 47 y | Lymph node, Stomach (Lym) | Diffuse B-cell lymphoma | Malignant | | | | |
| 1 | M19 | Human | M | 62 y | Lymph node (Lym) | Diffuse B-cell lymphoma | Malignant | | | | |
| 1 | M20 | Human | M | 77 y | Lymph node, Spleen (Lym) | Diffuse B-cell lymphoma | Malignant | | | | |
| 1 | M21 | Human | F | 46 y | Retroperitoneum (Ret) | Liposarcoma | Malignant | T2bN0M0 | | IB | Well |
| 1 | M22 | Human | F | 61 y | Retroperitoneum (Ret) | Liposarcoma | Malignant | T1bN0M0 | | IA | Well |
| 1 | M23 | Human | F | 27 y | Retroperitoneum (Ret) | Liposarcoma | Malignant | T2bN0M0 | | IB | Well |
| 1 | M24 | Human | M | 47 y | Retroperitoneum (Ret) | Liposarcoma | Malignant | T2bN0M0 | | IB | Well |
| 1 | M25 | Human | M | 68 y | Soft tissue, Leg (Sft) | Liposarcoma, Mucinous | Malignant | T1bN0M0 | | IIA | |
| 1 | N1 | Human | F | 29 y | Thyroid (Tyd) | Follicular carcinoma | Malignant | T1N0M0 | 2 | I | |
| 1 | N2 | Human | F | 48 y | Thyroid (Tyd) | Follicular carcinoma | Malignant | T2N0M0 | 2 | II | |
| 1 | N3 | Human | F | 49 y | Thyroid (Tyd) | Follicular carcinoma | Malignant | T3N0M1 | 3 | IV | |
| 1 | N4 | Human | M | 50 y | Thyroid (Tyd) | Follicular carcinoma | Malignant | T3N0M0 | 3 | II | |
| 1 | N5 | Human | F | 40 y | Thyroid (Tyd) | Follicular carcinoma | Malignant | T3N0M0 | 3 | I | |
| 1 | N6 | Human | M | 61 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N1M0 | 2 | II | |
| 1 | N7 | Human | M | 60 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N0M0 | 2 | I | |
| 1 | N8 | Human | M | 61 y | Lung (Lng) | Adenocarcinoma | Malignant | T1N0M0 | 2 | I | |
| 1 | N9 | Human | F | 54 y | Lung (Lng) | Adenocarcinoma | Malignant | T3N0M0 | 3 | IIIA | |
| 1 | N10 | Human | F | 45 y | Lung (Lng) | Adenocarcinoma | Malignant | T2N0M0 | 3 | I | |
| 1 | N11 | Human | M | 46 y | Fibrous tissue (Fib) | Squamous cell carcinoma | Malignant | T3N0M0 | | III | |
| 1 | N12 | Human | M | 60 y | Tongue (Tng) | Squamous cell carcinoma | Malignant | T1N0M0 | 3 | I | |
| 1 | N13 | Human | M | 62 y | Nasopharynx (Nsl) | Squamous cell carcinoma | Malignant | T1N0M0 | 3 | I | |
| 1 | N14 | Human | M | 50 y | Pharynx (Pyx) | Carcinoma sarcomatodes | Malignant | T3N1M0 | | III | |
| 1 | N15 | Human | M | 52 y | Larynx (Lrx) | Squamous cell carcinoma | Malignant | T3N0M0 | 3 | III | |
| 1 | N16 | Human | M | 16 y | Lymph node, Colon mucosa (Lym) | B cell lymphoma | Malignant | | | | |
| 1 | N17 | Human | M | 75 y | Lymph node, Stomach (Lym) | Diffuse B-cell lymphoma | Malignant | | | | |
| 1 | N18 | Human | M | 53 y | Lymph node, Mesenteric (Lym) | Diffuse B-cell lymphoma | Malignant | | | | |
| 1 | N19 | Human | M | 45 y | Lymph node, Stomach (Lym) | Diffuse B-cell lymphoma | Malignant | | | | |
| 1 | N20 | Human | M | 43 y | Lymph node, Stomach (Lym) | Diffuse B-cell lymphoma | Malignant | | | | |
| 1 | N21 | Human | F | 23 y | Soft tissue, Arm (Sft) | Liposarcoma, Mucinous | Malignant | T1bN0M0 | | IIA | |
| 1 | N22 | Human | F | 37 y | Soft tissue, Retroperitoneum (Sft) | Liposarcoma, Mucinous | Malignant | T2bN0M0 | | IIB | |
| 1 | N23 | Human | F | 71 y | Soft tissue, Retroperitoneum (Sft) | Liposarcoma, Mucinous | Malignant | T1aN0M0 | | IIA | |
| 1 | N24 | Human | M | 58 y | Soft tissue, Thigh (Sft) | Liposarcoma, Mucinous | Malignant | T1bN0M0 | | IIA | |
| 1 | N25 | Human | F | 58 y | Soft tissue, Pars sacralis (Sft) | Liposarcoma, Pleomorphic | Malignant | T2bN0M0 | | IIIB | |
| 1 | O1 | Human | M | 37 y | Thyroid (Tyd) | Normal | Benign non-neoplastic | | | | |
| 1 | O2 | Human | F | 58 y | Thyroid (Tyd) | Normal | Benign non-neoplastic | | | | |
| 1 | O3 | Human | M | 35 y | Thyroid (Tyd) | Normal | Benign non-neoplastic | | | | |
| 1 | O4 | Human | M | 50 y | Thyroid (Tyd) | Normal | Benign non-neoplastic | | | | |
| 1 | O5 | Human | M | 22 y | Thyroid (Tyd) | Normal | Benign non-neoplastic | | | | |
| 1 | O6 | Human | M | 49 y | Lung (Lng) | Normal | Benign non-neoplastic | | | | |
| 1 | O7 | Human | M | 42 y | Lung (Lng) | Normal | Benign non-neoplastic | | | | |
| 1 | O8 | Human | M | 55 y | Lung (Lng) | Normal | Benign non-neoplastic | | | | |
| 1 | O9 | Human | M | 22 y | Lung (Lng) | Normal | Benign non-neoplastic | | | | |
| 1 | O10 | Human | M | 50 y | Lung (Lng) | Normal | Benign non-neoplastic | | | | |
| 1 | O11 | Human | M | 45 y | Skin (Skn) | Normal | Benign non-neoplastic | | | | |
| 1 | O12 | Human | M | 30 y | Skin (Skn) | Normal | Benign non-neoplastic | | | | |
| 1 | O13 | Human | M | 47 y | Skin (Skn) | Normal | Benign non-neoplastic | | | | |
| 1 | O14 | Human | F | 18 y | Skin (Skn) | Normal | Benign non-neoplastic | | | | |
| 1 | O15 | Human | M | 43 y | Skin (Skn) | Normal | Benign non-neoplastic | | | | |
| 1 | O16 | Human | M | 44 y | Lymph node, Stomach (Lym) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | O17 | Human | F | 55 y | Lymph node, Esophagus (Lym) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | O18 | Human | F | 63 y | Lymph node, Esophagus (Lym) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | O19 | Human | F | 50 y | Lymph node, Rectum (Lym) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | O20 | Human | F | 70 y | Lymph node, Esophagus (Lym) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | O21 | Human | M | 60 y | Lymph node, Stomach (Lym) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | O22 | Human | M | 61 y | Lymph node, Stomach (Lym) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | O23 | Human | M | 55 y | Lymph node, Sigmoid colon (Lym) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | O24 | Human | M | 61 y | Lymph node, Stomach (Lym) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | O25 | Human | M | 44 y | Lymph node, Cardia (Lym) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | P1 | Human | M | 45 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | T3N0M0 | 2 | III | |
| 1 | P2 | Human | M | 46 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | T3N0M0 | 2 | III | |
| 1 | P3 | Human | M | 47 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | T3N0M0 | 2 | III | |
| 1 | P4 | Human | M | 43 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | T3N0M0 | 2 | III | |
| 1 | P5 | Human | M | 42 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | T2N0M0 | 2 | II | |
| 1 | P6 | Human | M | 60 y | Pancreas (Pnc) | Ductal adenocarcinoma | Malignant | T3N0M0 | 2 | II | |
| 1 | P7 | Human | F | 50 y | Pancreas (Pnc) | Ductal adenocarcinoma with necrosis | Malignant | T2N0M0 | | I | |
| 1 | P8 | Human | M | 65 y | Pancreas (Pnc) | Ductal adenocarcinoma | Malignant | T2N0M0 | 2 | I | |
| 1 | P9 | Human | M | 70 y | Pancreas (Pnc) | Ductal adenocarcinoma | Malignant | T2N0M0 | | I | |
| 1 | P10 | Human | F | 75 y | Pancreas (Pnc) | Ductal adenocarcinoma | Malignant | T3N0M1 | 2-3 | IV | |
| 1 | P11 | Human | M | 46 y | Kidney (Kid) | Clear cell carcinoma | Malignant | T1N0M0 | 2 | I | |
| 1 | P12 | Human | M | 59 y | Kidney (Kid) | Clear cell carcinoma | Malignant | T1N0M0 | 2 | I | |
| 1 | P13 | Human | M | 46 y | Kidney (Kid) | Clear cell carcinoma | Malignant | T1N0M0 | 2 | I | |
| 1 | P14 | Human | M | 59 y | Kidney (Kid) | Clear cell carcinoma | Malignant | T1N0M0 | 2 | I | |
| 1 | P15 | Human | M | 76 y | Kidney (Kid) | Clear cell carcinoma | Malignant | T1N0M0 | 2 | I | |
| 1 | P16 | Human | F | 50 y | Skin, Vulva (Skn) | Squamous cell carcinoma | Malignant | T1N0M0 | 1 | I | |
| 1 | P17 | Human | M | 60 y | Skin, Limb (Skn) | Squamous cell carcinoma | Malignant | T2N0M0 | 1 | II | |
| 1 | P18 | Human | F | 85 y | Skin, Vulva (Skn) | Squamous cell carcinoma | Malignant | T1N0M0 | 1 | I | |
| 1 | P19 | Human | M | 56 y | Skin, Lip (Skn) | Squamous cell carcinoma | Malignant | T2N0M0 | 1 | II | |
| 1 | P20 | Human | F | 58 y | Skin, Vulva (Skn) | Squamous cell carcinoma | Malignant | T2N0M0 | 2 | II | |
| 1 | P21 | Human | M | 60 y | Lung (Lng) | Large cell carcinoma | Malignant | T2N0M0 | | I | |
| 1 | P22 | Human | M | 70 y | Lung (Lng) | Large cell carcinoma | Malignant | T2N0M0 | | I | |
| 1 | P23 | Human | F | 54 y | Lung (Lng) | Large cell carcinoma | Malignant | T2N1M0 | | II | |
| 1 | P24 | Human | M | 64 y | Lung (Lng) | Large cell carcinoma | Malignant | T2N0M0 | | I | |
| 1 | P25 | Human | M | 62 y | Lung (Lng) | Large cell carcinoma | Malignant | T2N0M0 | | I | |
| 1 | Q1 | Human | M | 67 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | T3N0M0 | 2 | III | |
| 1 | Q2 | Human | M | 63 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | T3N0M0 | 2 | III | |
| 1 | Q3 | Human | M | 45 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | T3N0M0 | 2 | III | |
| 1 | Q4 | Human | F | 52 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | T3N0M0 | 2 | III | |
| 1 | Q5 | Human | F | 48 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | T3N0M0 | 2 | III | |
| 1 | Q6 | Human | M | 65 y | Pancreas (Pnc) | Ductal adenocarcinoma | Malignant | T3N0M0 | 3 | II | |
| 1 | Q7 | Human | F | 68 y | Pancreas (Pnc) | Ductal adenocarcinoma | Malignant | T2N0M0 | | I | |
| 1 | Q8 | Human | M | 61 y | Pancreas, Fibrous tissue and blood vessel (Pnc) | Ductal adenocarcinoma | Malignant | T2N0M0 | | I | |
| 1 | Q9 | Human | F | 53 y | Pancreas (Pnc) | Ductal adenocarcinoma | Malignant | T3N0M0 | 3 | II | |
| 1 | Q10 | Human | F | 67 y | Pancreas, Fibrous tissue and blood vessel (Pnc) | Ductal adenocarcinoma | Malignant | T3N0M0 | | II | |
| 1 | Q11 | Human | M | 70 y | Kidney (Kid) | Clear cell carcinoma | Malignant | T1N0M0 | 1 | I | |
| 1 | Q12 | Human | M | 40 y | Kidney (Kid) | Clear cell carcinoma | Malignant | T1N0M0 | 1 | I | |
| 1 | Q13 | Human | M | 76 y | Kidney (Kid) | Clear cell carcinoma | Malignant | T4N0M0 | 1 | IV | |
| 1 | Q14 | Human | F | 59 y | Kidney (Kid) | Clear cell carcinoma | Malignant | T1N0M0 | 1 | I | |
| 1 | Q15 | Human | M | 60 y | Kidney (Kid) | Clear cell carcinoma | Malignant | T1N0M0 | 2 | I | |
| 1 | Q16 | Human | F | 49 y | Skin, Vulva (Skn) | Squamous cell carcinoma | Malignant | T1N0M0 | 1 | I | |
| 1 | Q17 | Human | F | 70 y | Skin, Vulva (Skn) | Squamous cell carcinoma | Malignant | T1N0M0 | 1 | I | |
| 1 | Q18 | Human | F | 90 y | Skin, Face (Skn) | Squamous cell carcinoma | Malignant | T2N0M0 | 1 | II | |
| 1 | Q19 | Human | F | 68 y | Skin, Face (Skn) | Squamous cell carcinoma | Malignant | T1N0M0 | 1 | I | |
| 1 | Q20 | Human | M | 82 y | Skin, Head (Skn) | Squamous cell carcinoma | Malignant | T1N0M0 | 1 | I | |
| 1 | Q21 | Human | M | 54 y | Lung (Lng) | Small cell carcinoma | Malignant | T2N0M0 | | I | |
| 1 | Q22 | Human | M | 34 y | Lung (Lng) | Small cell carcinoma | Malignant | T2N0M0 | | I | |
| 1 | Q23 | Human | M | 59 y | Lung (Lng) | Small cell carcinoma | Malignant | T2N1M0 | | II | |
| 1 | Q24 | Human | F | 53 y | Lung (Lng) | Small cell carcinoma | Malignant | T2N1M0 | | II | |
| 1 | Q25 | Human | M | 54 y | Lung (Lng) | Small cell carcinoma | Malignant | T2N1M0 | | II | |
| 1 | R1 | Human | F | 64 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | T3N0M0 | 2 | III | |
| 1 | R2 | Human | M | 37 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | T3N0M0 | 2 | III | |
| 1 | R3 | Human | F | 48 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | T3N0M0 | 2 | III | |
| 1 | R4 | Human | F | 47 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | T3N0M0 | 2 | III | |
| 1 | R5 | Human | M | 35 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | T3N0M0 | 2 | III | |
| 1 | R6 | Human | F | 54 y | Pancreas (Pnc) | Ductal adenocarcinoma | Malignant | T3N0M0 | 2 | II | |
| 1 | R7 | Human | F | 47 y | Pancreas (Pnc) | Ductal adenocarcinoma | Malignant | T3N1M0 | 2 | III | |
| 1 | R8 | Human | M | 60 y | Pancreas (Pnc) | Ductal adenocarcinoma | Malignant | T3N0M0 | 2-3 | II | |
| 1 | R9 | Human | M | 50 y | Pancreas (Pnc) | Ductal adenocarcinoma | Malignant | T2N1M0 | 2 | III | |
| 1 | R10 | Human | M | 55 y | Pancreas (Pnc) | Ductal adenocarcinoma | Malignant | T3N0M0 | 2 | II | |
| 1 | R11 | Human | M | 53 y | Kidney (Kid) | Granular cell carcinoma | Malignant | T3N0M0 | 2 | II | |
| 1 | R12 | Human | F | 76 y | Kidney (Kid) | Granular cell carcinoma | Malignant | T1N0M0 | 2 | I | |
| 1 | R13 | Human | F | 71 y | Kidney (Kid) | Granular cell carcinoma | Malignant | T1N0M0 | 2 | I | |
| 1 | R14 | Human | M | 41 y | Kidney (Kid) | Granular cell carcinoma | Malignant | T2N0M0 | 2 | II | |
| 1 | R15 | Human | M | 71 y | Kidney (Kid) | Granular cell carcinoma | Malignant | T1N0M0 | 2 | I | |
| 1 | R16 | Human | F | 47 y | Breast (Bst) | Lobular carcinoma, infiltrating | Malignant | T4N0M0 | | IIIB | |
| 1 | R17 | Human | F | 45 y | Breast (Bst) | Lobular carcinoma, infiltrating | Malignant | T2N0M0 | | IIA | |
| 1 | R18 | Human | F | 64 y | Breast (Bst) | Lobular carcinoma, infiltrating | Malignant | T2N0M0 | | IIA | |
| 1 | R19 | Human | F | 49 y | Breast, Fibrous tissue and blood vessel (Bst) | Lobular carcinoma, infiltrating | Malignant | T2N1M0 | | IIB | |
| 1 | R20 | Human | F | 47 y | Breast (Bst) | Lobular carcinoma, infiltrating | Malignant | T2N1M0 | | IIB | |
| 1 | R21 | Human | F | 12 y | Ovary (Ova) | Dysgerminoma | Malignant | T1bN0M0 | | IB | |
| 1 | R22 | Human | F | 14 y | Ovary (Ova) | Endodermal sinus carcinoma | Malignant | T1cN0M0 | | IC | |
| 1 | R23 | Human | F | 32 y | Ovary (Ova) | Endodermal sinus carcinoma | Malignant | T1cN0M1 | | IV | |
| 1 | R24 | Human | F | 16 y | Ovary (Ova) | Endodermal sinus carcinoma | Malignant | T2N0M1 | | IV | |
| 1 | R25 | Human | F | 22 y | Ovary (Ova) | Endodermal sinus carcinoma | Malignant | T1cN0M0 | | IC | |
| 1 | S1 | Human | F | 62 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | T3N0M0 | 3 | III | |
| 1 | S2 | Human | M | 38 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | T3N0M0 | 3 | III | |
| 1 | S3 | Human | M | 64 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | T2N0M0 | 3 | II | |
| 1 | S4 | Human | M | 46 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | T3N0M0 | 3 | III | |
| 1 | S5 | Human | M | 35 y | Liver (Liv) | Hepatocellular carcinoma | Malignant | T2N0M0 | 3 | II | |
| 1 | S6 | Human | M | 44 y | Pancreas (Pnc) | Ductal adenocarcinoma | Malignant | T3N0M0 | 2 | II | |
| 1 | S7 | Human | M | 61 y | Pancreas (Pnc) | Ductal adenocarcinoma | Malignant | T3N0M1 | 3 | IV | |
| 1 | S8 | Human | M | 41 y | Pancreas (Pnc) | Ductal adenocarcinoma | Malignant | T4N1M0 | 2 | III | |
| 1 | S9 | Human | M | 62 y | Pancreas (Pnc) | Ductal adenocarcinoma | Malignant | T3N1M0 | 3 | III | |
| 1 | S10 | Human | F | 57 y | Pancreas (Pnc) | Ductal adenocarcinoma | Malignant | T2N0M0 | 3 | I | |
| 1 | S11 | Human | M | 53 y | Kidney (Kid) | Granular cell carcinoma | Malignant | T1N0M0 | 3 | I | |
| 1 | S12 | Human | F | 57 y | Kidney (Kid) | Granular cell carcinoma | Malignant | T1N0M0 | 2 | I | |
| 1 | S13 | Human | M | 58 y | Kidney (Kid) | Granular cell carcinoma | Malignant | T1N0M0 | 2 | I | |
| 1 | S14 | Human | F | 42 y | Kidney (Kid) | Granular cell carcinoma with necrosis | Malignant | T2N0M0 | | II | |
| 1 | S15 | Human | F | 49 y | Kidney (Kid) | Granular cell carcinoma | Malignant | T2N0M0 | 3 | II | |
| 1 | S16 | Human | F | 39 y | Breast (Bst) | Lobular carcinoma, infiltrating | Malignant | T2N0M0 | | IIA | |
| 1 | S17 | Human | F | 53 y | Breast (Bst) | Lobular carcinoma, infiltrating | Malignant | T2N0M0 | | IIA | |
| 1 | S18 | Human | F | 46 y | Breast (Bst) | Lobular carcinoma, infiltrating | Malignant | T3N0M0 | | IIB | |
| 1 | S19 | Human | F | 52 y | Breast (Bst) | Lobular carcinoma, infiltrating | Malignant | T2N1M0 | | IIB | |
| 1 | S20 | Human | F | 58 y | Breast (Bst) | Lobular carcinoma, infiltrating | Malignant | T2N0M0 | | IIA | |
| 1 | S21 | Human | F | 76 y | Ovary (Ova) | Granular cell tumor | Tumor | T1cN0M0 | | IC | |
| 1 | S22 | Human | F | 51 y | Ovary (Ova) | Granular cell tumor | Tumor | T1bN0M0 | | IB | |
| 1 | S23 | Human | F | 55 y | Ovary (Ova) | Granular-theca cell tumor | Tumor | | | | |
| 1 | S24 | Human | F | 46 y | Ovary (Ova) | Fibrosarcoma | Malignant | T2N0M0 | | IB | |
| 1 | S25 | Human | F | 49 y | Ovary (Ova) | Fibrosarcoma | Malignant | T2bN0M0 | | IB | |
| 1 | T1 | Human | M | 56 y | Liver (Liv) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | T2 | Human | M | 55 y | Liver (Liv) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | T3 | Human | F | 38 y | Liver (Liv) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | T4 | Human | M | 60 y | Liver (Liv) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | T5 | Human | M | 34 y | Liver (Liv) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | T6 | Human | F | 38 y | Pancreas (Pnc) | Normal | Benign non-neoplastic | | | | |
| 1 | T7 | Human | F | 35 y | Pancreas (Pnc) | Normal | Benign non-neoplastic | | | | |
| 1 | T8 | Human | M | 5 mo | Pancreas (Pnc) | Normal | Benign non-neoplastic | | | | |
| 1 | T9 | Human | F | 38 y | Pancreas (Pnc) | Normal | Benign non-neoplastic | | | | |
| 1 | T10 | Human | M | 40 y | Pancreas (Pnc) | Normal | Benign non-neoplastic | | | | |
| 1 | T11 | Human | M | 54 y | Kidney (Kid) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | T12 | Human | M | 56 y | Kidney (Kid) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | T13 | Human | F | 47 y | Kidney (Kid) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | T14 | Human | F | 61 y | Kidney (Kid) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | T15 | Human | M | 54 y | Kidney (Kid) | Adjacent normal | Benign non-neoplastic | | | | |
| 1 | T16 | Human | F | 53 y | Breast (Bst) | Ductal carcinoma in situ | Malignant | TisN0M0 | | | |
| 1 | T17 | Human | F | 30 y | Breast (Bst) | Intraductal carcinoma | Malignant | TisN0M0 | | | |
| 1 | T18 | Human | F | 49 y | Breast (Bst) | Lobular carcinoma in situ | Malignant | TisN0M0 | | | |
| 1 | T19 | Human | F | 48 y | Breast (Bst) | Fibroadenoma | Tumor | | | | |
| 1 | T20 | Human | F | 35 y | Breast, Fibrous tissue (Bst) | Fibroadenoma | Tumor | | | | |
| 1 | T21 | Human | F | 35 y | Ovary (Ova) | Ovarian teratoma | Tumor | | | | |
| 1 | T22 | Human | F | 8 y | Ovary (Ova) | Ovarian teratoma | Tumor | | | | |
| 1 | T23 | Human | F | 15 y | Ovary (Ova) | Ovarian teratoma | Tumor | | | | |
| 1 | T24 | Human | F | 41 y | Ovary (Ova) | Papilloma, serous | Tumor | | | | |
| 1 | T25 | Human | F | 50 y | Ovary (Ova) | Cystadenoma, Mucinous | Tumor | | | | |